Table 3.

Significant correlations between biomarker values in tumors

rP
Pretreatment ALL
    EREGFR0.270.015
    PRBcl-20.240.040
Bcl-xL0.140.031
    pY-SrcBcl-20.220.028
Bcl-xL0.360.024
Ki-670.390.016
    pY-Stat3HER2/neu0.370.017
Survivin0.290.032
Pretreatment-CPR
    BCL-2Bcl-xL0.650.020
PR0.690.007
    pY-Stat3HER2/neu0.540.048
pY-Src0.660.028
    SurvivinEGFR0.720.088
Pretreatment PPR
    EREGFR0.370.025
    pY-SrcBcl-20.270.009
Bcl-xL0.420.036
EGFR0.410.014
    pY-Stat3ER0.410.050
Survivin0.530.001
Posttreatment PPR
    HER2/neuKi-670.390.024
    EGFRpY-Src−0.380.028
  • NOTE: Spearman's test was used to identify statistically significant correlations among the expression levels of biomarkers in tumors. Only statistically significant correlations (P ≤ 0.05) are shown, together with the correlation coefficient (r).